India's Torrent Pharmaceuticals is set to raise up to 125 billion rupees ($1.4 billion) through short-duration bond sales in January, in one of the latest acquisition-funding deals, two bankers said.

The Cybersecurity Imperative for Indian Pharma Manufacturing in 2025 India’s pharmaceutical manufacturing sector is a ...

Indian pharmaceutical market (IPM) has registered a growth of 8.1 percent to touch ₹2,40,672 crore in 2025 and is likely to ...

India’s pharmaceutical sector is heading into a split-screen 2026, with brokerage commentary pointing to a year marked by ...

India’s pharmaceutical exports reached $30.47 billion in FY 2024–25, registering a 9.4 per cent year-on-year growth, and are ...

India’s pharmaceutical exports reached US$ 30.47 billion in FY 2024–25, and the sector remains optimistic about further growth, driven by strong global demand and resilient production capabilities.

The Union Budget 2026-27 aims to pivot India’s pharmaceutical and medical devices sectors from high-volume, low-value production to high-value manufacturing, enhancing global competitiveness and ...

The Swiss market‑expansion services group is in talks with potential acquisition targets and expects an entry to take shape ...

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming for a USD 500 billion valuation by 2047.